The aim of medical care is to improve survival and quality of life for patients. Those with long-term and life-limiting conditions have particular needs due to the progressive and/or long-term nature of the underlying pathophysiology. However, it is now clear that patients who are engaged in their own health and treatment may have better outcomes. Biopharma companies that take a proactive approach to patient centric care are more likely to see outcomes similar to those anticipated from clinical trial data. This can be facilitated and supported through patient support programs (PSPs) that are not only tailored to the disease type and stage, but also to the patient’s preferences and situation, adapting over time according to need. Effective support programs which combine human interaction with technology to empower and educate patients may have both short- and long-term impact on patient outcomes and healthcare utilisation.
Source: Pharma Horizon
Volume 1 (1) 2017http://www.teknoscienze.com/pharma-horizon/